Provided by Tiger Trade Technology Pte. Ltd.

Theravance Biopharma

17.03
+0.02000.12%
Post-market: 17.030.00000.00%16:10 EDT
Volume:332.38K
Turnover:5.66M
Market Cap:882.64M
PE:16.30
High:17.07
Open:17.02
Low:17.00
Close:17.01
52wk High:21.03
52wk Low:13.08
Shares:51.83M
Float Shares:25.78M
Volume Ratio:0.89
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.05
EPS(LYR):2.06
ROE:20.91%
ROA:1.33%
PB:3.05
PE(LYR):8.27

Loading ...

Theravance Biopharma details Phase 3 ampreloxetine data

TIPRANKS
·
1 hour ago

Theravance Biopharma, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Metagenomi Q2 Net Loss Widens Cash Runway Seen Through 2027

Reuters
·
Aug 11

Rocket Pharmaceuticals Posts Q2 Profit Helped by PRV Sale

Reuters
·
Aug 11

Enanta Pharmaceuticals Q3 Revenue Misses Estimates, Hurt by Lower Royalties

Reuters
·
Aug 11

Olema Pharmaceuticals Q2 Net Loss Widens on Higher Clinical Trial Spending

Reuters
·
Aug 11

Biohaven Q2 Net Loss Narrows on Lower R&D Spend

Reuters
·
Aug 11

Theravance Biopharma Swings to Net Loss in Q2, Revenue Falls

MT Newswires Live
·
Aug 10

Ireland's Theravance Biopharma Q2 Revenue Rises 11% but Misses Estimates

Reuters
·
Aug 10

Theravance Biopharma Q2 Adj. EPS $0.18 Beats $0.05 Estimate, Sales $20.731M Miss $21.600M Estimate

Benzinga Earnings
·
Aug 10

Earnings Flash (TBPH) Theravance Biopharma Posts Q2 Net Loss $0.11 a Share, vs. FactSet Est of $0.07 EPS

MT Newswires Live
·
Aug 10

Theravance Biopharma Q2 Operating Income USD -8.277 Million

Reuters
·
Aug 10

Theravance Biopharma Q2 Net Income USD -5.898 Million

THOMSON REUTERS
·
Aug 10

Zymeworks Revenue Drops 90.57% to $4.6 Million in FY26 Q2; Net Loss Widens to $45 Million

Reuters
·
Aug 07

Zymeworks to Report Q2 Results After Market Close

Reuters
·
Jul 16

Major Theravance Biopharma Investor Makes Notable Stock Move

TIPRANKS
·
Jul 09

Theravance Biopharma 10% Owner Eli Samaha Disposes of USD 119,359 in Common Shares

Reuters
·
Jul 09

Theravance Biopharma Cut to Neutral from Buy by HC Wainwright & Co.

Dow Jones
·
Jul 07

Theravance Biopharma Inc : H.c. Wainwright Cuts to Neutral Rating

THOMSON REUTERS
·
Jul 07

Zymeworks Said to Near $929 Million Deal for Theravance - Bloomberg News

Reuters
·
Jul 03